Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms.
暂无分享,去创建一个
L. Vanes | V. Tybulewicz | S. Bregenholt | F. Colucci | E. Rosmaraki | V. Bartolo | J. P. Santo | S. Samson | M. Turner | Eleftheria E. Rosmaraki | Lesley Vanes | Sandrine I. Samson
[1] L. Eisenlohr,et al. Differential Role of p38 and c-Jun N-Terminal Kinase 1 Mitogen-Activated Protein Kinases in NK Cell Cytotoxicity1 , 2000, The Journal of Immunology.
[2] P. Leibson,et al. The Rho Family Guanine Nucleotide Exchange Factor Vav-2 Regulates the Development of Cell-Mediated Cytotoxicity , 2000, The Journal of experimental medicine.
[3] J. Cleveland,et al. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. , 2000, Immunity.
[4] B. Pulendran,et al. Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells. , 2000, Blood.
[5] R. Biassoni,et al. Natural cytotoxicity receptors that trigger human NK-cell-mediated cytolysis. , 2000, Immunology today.
[6] P. Morrissey,et al. Reversible Defects in Natural Killer and Memory Cd8 T Cell Lineages in Interleukin 15–Deficient Mice , 2000, The Journal of experimental medicine.
[7] P. Berche,et al. The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes , 2000, Molecular microbiology.
[8] J. Trapani,et al. Differential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells , 2000, The Journal of experimental medicine.
[9] J. D. Di Santo,et al. The receptor tyrosine kinase c-kit provides a critical signal for survival, expansion, and maturation of mouse natural killer cells. , 2000, Blood.
[10] M. Turner,et al. Redundant role of the Syk protein tyrosine kinase in mouse NK cell differentiation. , 1999, Journal of immunology.
[11] K. Tedford,et al. The oncogene product Vav is a crucial regulator of primary cytotoxic T cell responses but has no apparent role in CD28‐mediated co‐stimulation , 1999, European journal of immunology.
[12] M. Turner,et al. The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[13] L. Frati,et al. Role for the Rac1 exchange factor Vav in the signaling pathways leading to NK cell cytotoxicity. , 1999, Journal of immunology.
[14] J. D. Di Santo,et al. Dissecting NK cell development using a novel alymphoid mouse model: investigating the role of the c-abl proto-oncogene in murine NK cell differentiation. , 1999, Journal of immunology.
[15] L. Eisenlohr,et al. Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases. , 1998, Journal of immunology.
[16] J. Penninger,et al. Vav Regulates Peptide-specific Apoptosis in Thymocytes , 1998, The Journal of experimental medicine.
[17] I. Puzanov,et al. Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems , 1998, Immunological reviews.
[18] T. Ley,et al. How do cytotoxic lymphocytes kill their targets? , 1998, Current opinion in immunology.
[19] X. Bustelo,et al. The Vav–Rac1 Pathway in Cytotoxic Lymphocytes Regulates the Generation of Cell-mediated Killing , 1998, The Journal of experimental medicine.
[20] D. Cantrell. Lymphocyte signalling: A coordinating role for Vav? , 1998, Current Biology.
[21] Sebastian Amigorena,et al. Deficient Peptide Loading and MHC Class II Endosomal Sorting in a Human Genetic Immunodeficiency Disease: the Chediak-Higashi Syndrome , 1998, The Journal of cell biology.
[22] Jin Hong Liu,et al. Control of Lytic Function by Mitogen-activated Protein Kinase/Extracellular Regulatory Kinase 2 (ERK2) in a Human Natural Killer Cell Line: Identification of Perforin and Granzyme B Mobilization by Functional ERK2 , 1998, The Journal of experimental medicine.
[23] K. Tedford,et al. Vav is a regulator of cytoskeletal reorganization mediated by the T-cell receptor , 1998, Current Biology.
[24] F. Alt,et al. Defects in actin-cap formation in Vav-deficient mice implicate an actin requirement for lymphocyte signal transduction , 1998, Current Biology.
[25] D. Fearon,et al. CD19 as a membrane-anchored adaptor protein of B lymphocytes: costimulation of lipid and protein kinases by recruitment of Vav. , 1998, Immunity.
[26] J. Dorfman,et al. Acquisition of Ly49 Receptor Expression by Developing Natural Killer Cells , 1998, The Journal of experimental medicine.
[27] W. Yokoyama,et al. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement. , 1998, Cellular immunology.
[28] M. White,et al. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. , 1998, Science.
[29] R. Zamoyska,et al. A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. , 1997, Immunity.
[30] P. Leibson. Signal transduction during natural killer cell activation: inside the mind of a killer. , 1997, Immunity.
[31] T. L. Collins,et al. Views on Vav. , 1997, Immunology today.
[32] L. Frati,et al. CD16 cross-linking induces both secretory and extracellular signal-regulated kinase (ERK)-dependent cytosolic phospholipase A2 (PLA2) activity in human natural killer cells: involvement of ERK, but not PLA2, in CD16-triggered granule exocytosis. , 1997, Journal of immunology.
[33] K. Schuebel,et al. Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product , 1997, Nature.
[34] M. Olson,et al. Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases , 1996, Current Biology.
[35] T. Moore,et al. Inhibition of gamma delta T cell development and early thymocyte maturation in IL-7 -/- mice. , 1996, Journal of immunology.
[36] A. Chong,et al. Vav in natural killer cells is tyrosine phosphorylated upon cross-linking of Fc gamma RIIIA and is constitutively associated with a serine/threonine kinase. , 1996, The Biochemical journal.
[37] M. Barbacid,et al. Rac-1 dependent stimulation of the JNK/SAPK signaling pathway by Vav. , 1996, Oncogene.
[38] M. Lovett,et al. Identification of the homologous beige and Chediak–Higashi syndrome genes , 1996, Nature.
[39] M. Barbacid,et al. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+CDS+thymocytes , 1995, Nature.
[40] K. Rajewsky,et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav , 1995, Nature.
[41] F. Alt,et al. Defective signalling through the T- and B-cell antigen receptors in lymphoid cells lacking the vav proto-oncogene , 1995, Nature.
[42] R. Abraham,et al. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity , 1994, The Journal of experimental medicine.
[43] L. Platanias,et al. Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells. , 1994, The Journal of biological chemistry.
[44] I. Lemischka,et al. Mitogenic signalling and substrate specificity of the Flk2/Flt3 receptor tyrosine kinase in fibroblasts and interleukin 3-dependent hematopoietic cells , 1993, Molecular and cellular biology.
[45] M. Barbacid,et al. Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells. , 1992, The Journal of biological chemistry.
[46] Amos Bairoch,et al. Proto-vav and gene expression , 1992, Nature.
[47] T. Lints,et al. The hematopoietically expressed vav proto-oncogene shares homology with the dbl GDP-GTP exchange factor, the bcr gene and a yeast gene (CDC24) involved in cytoskeletal organization. , 1992, Oncogene.
[48] V. Stewart,et al. RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement , 1992, Cell.
[49] A. Ullrich,et al. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs , 1992, Nature.
[50] M. Barbacid,et al. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates , 1992, Nature.
[51] H. Ljunggren,et al. Alteration of the natural killer repertoire in H-2 transgenic mice: specificity of rapid lymphoma cell clearance determined by the H-2 phenotype of the target , 1991, The Journal of experimental medicine.
[52] E. Unanue,et al. Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli , 1991, Infection and immunity.
[53] G. Trinchieri,et al. Biology of Natural Killer Cells , 1989, Advances in Immunology.
[54] M. Barbacid,et al. vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. , 1989, The EMBO journal.
[55] H. Ljunggren,et al. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.
[56] C. Biron,et al. Natural killer cells in antiviral defense: function and regulation by innate cytokines. , 1999, Annual review of immunology.
[57] L. Lanier. NK cell receptors. , 1998, Annual review of immunology.